Skip to content

Multidomain Intervention to Prevent Disability in Elders

Multidomain Intervention to Prevent Disability in Elders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02082171
Acronym
MINDED
Enrollment
210
Registered
2014-03-10
Start date
2013-10-16
Completion date
2016-01-27
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobility Disability, Physical Disability, Physical Frailty

Keywords

older adults, physical disability, multidomain intervention, prevention, pilot study, frailty, mobility, comprehensive geriatric assessment

Brief summary

Prevention of physical disability represents a major priority for the public health system. Physical disability is the final result of a complex cascade of negative events occurring at different levels (i.e., environmental, social, biological, and clinical). The heterogeneity of the underlying mechanisms responsible for the onset of physical disability may require the adoption of preventive interventions affecting multiple domains. Although several studies suggest that single or different combinations of preventive interventions (in particular, physical activity, cognitive training, and healthy diet) might provide beneficial effects in preventing functional loss (and its related features, such as pain or reduced quality of life), very limited evidence coming from clinical trials is currently available on the topic. Intervention trials are usually designed to test the effect of a specific monodimensional intervention on a very selected population, so to reduce the risk of biased results. This approach, although legitimate and methodologically correct, may 1) be insufficient to target the multiple and heterogeneous physiopathological mechanisms underlying the onset of physical disability, and 2) cause a population selection bias leading to difficulties in implementing the study results to the overall older population (thus, determining the evidence-based medicine issue in the elderly). To our knowledge, there are no available data from clinical trials evaluating the effects of a multidomain intervention based on lifestyle modifications (e.g., physical activity, cognitive training, nutritional modification) for preventing mobility disability (a very early phase of the disabling process) in community-dwelling older persons. In the present project (Multidomain Intervention to preveNt Disability in ElDers, MINDED), we propose to conduct a pilot study aimed at estimating the effects of a multidomain person-tailored preventive intervention (based on physical activity, cognitive training, and nutritional modifications) on frailty status, physical performance, cognitive function, nutritional status, health-related quality of life, and use of health care services. In addition, we will perform cost-effectiveness analyses of the proposed intervention. The project will yield the necessary preliminary data to design a definitive full-scale Phase 3 randomized clinical trial. By providing a conclusive answer about the effectiveness of a multidimensional preventive program in the primary prevention of major health-related outcomes, the results of the full-scale trial will have relevant clinical and public health implications, and will promote the practicing of a truly evidence-based geriatric medicine.

Interventions

Multidomain preventive intervention designed by a multidisciplinary team on the basis of results of a comprehensive geriatric assessment

Sponsors

National Research Agency, France
CollaboratorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age of 60 years and older; * Willingness to be randomized to either treatment group; * Pre-frailty or frailty status according to the phenotype described by Fried and colleagues

Exclusion criteria

* Failure to provide informed consent; * Inability to complete a 400-meter walk test (primary outcome of the study); * Living in nursing home; * Living outside of the area of interest, or planning to move out of the area in next 3 years, or planning to leave the area for more than 3 months during the next year; * Relevant cognitive impairment (defined as a known diagnosis of dementia); * Severe progressive, degenerative neurologic disease (e.g., multiple sclerosis); * Severe rheumatologic or orthopaedic diseases (e.g., awaiting joint replacement); * Terminal illness with life expectancy less than 12 months; * Severe pulmonary disease (e.g., oxygen therapy or chronic use of steroids); * Severe cardiac disease (e.g., New York Heart Association Class III or IV heart failure, clinically significant aortic stenosis, history of cardiac arrest, uncontrolled angina); * Other significant comorbid conditions that would impair the ability to participate in the multidomain intervention (e.g., renal failure on hemodialysis, severe psychiatric disorder, excessive alcohol use). To be noted: persons with depression will not be excluded.

Design outcomes

Primary

MeasureTime frameDescription
400-meter walk test12 monthsIncident inability to complete the 400-meter walk test in the two randomization groups

Secondary

MeasureTime frameDescription
Intercurrent illnesses rates12 monthsIntercurrent illnesses rates in the two randomization groups
Serious fall injuries12 monthsIncident fall injuries occurred in the two randomization groups
Hospitalizations and institutionalization rates12 monthsIncidence of acute care hospitalizations and nursing home admissions in the two randomization groups
Mortality12 monthsOverall mortality rate in the two randomization groups
Participants' adherence/retention to the intervention protocol and control groups12 monthsParticipants' adherence/retention to the intervention protocol
Body composition modifications12 monthsBody composition modifications (assessed using bioimpedance analysis) in the two randomization groups
Modification of Pain12 monthsModification of pain symptoms in the two randomization groups
Fatigue12 monthsModification of the fatigue symptom in the two randomization groups
Health-related quality of life12 monthsModifications of health-related quality of life in the two randomization groups

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026